Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2012 /
Epigenetics of cancer and changes in DNA modification in tumours

7th - 10th Jul 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.07.12
Views: 3771
Rating:

Prof Manel Esteller – University of Barcelona, Catalonia, Spain

Prof Manel Esteller talks to ecancer at EACR 22 in Barcelona, July 2012, about how all tumour types can be affected by gene modification.

 

It is important to understand that cancer is not only an accumulation of mutations, but genetic defects as well. In cancer, genetic information provides biomarkers that help determine diagnostic, prognostic and treatment effects; in addition to targets for new drugs.

 

Current developments in gene therapy include new techniques for genetic modification and de-modification, which show promise in leukaemia and sarcomas, as well as new interests in colorectal, breast and small cell lung cancer.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation